Cancer BiologyNature CommunicationsPeer-reviewed
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model
8 citationstop 1%
Author
Harvard UniversityORCID 0000-0002-3900-5023Unclaimed ORCID profile · follow to get notified of new preprints
2 papers
Recent·Most cited
Zhenzhen Yin, Simeng Lu, Limeng Wu…·Lei Xu
This study shows that combining anti-PD1 treatment with radiation therapy for vestibular schwannomas improves tumor control, reduces radiation dose, and elicits systemic anti-tumor effects.